关于神经退行性疾病中TLR-4介导炎症通路的机制性见解
Veerta Sharma1, Prateek Sharma1, Thakur Gurjeet Singh2
1Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Pharmacological reports : PR
|June 25, 2024
概括
针对Toll-like受体-4 (TLR-4) 和核因子-kappa B (NF-κB) 的新型药物显示出治疗神经退行性疾病的前景. 这项研究探讨了它们对抗阿尔茨海默症和帕金森症等疾病的潜力.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 分子生物学和免疫学 分子生物学和免疫学
背景情况:
- 神经退行性疾病 (NDD) 是一个主要的医疗保健挑战,由复杂的分子机制驱动.
- 神经炎症,由细胞信号通路介导,包括托尔类受体 (TLR) 和核因子-卡帕B (NF-κB) 激活,在NDD病变发生过程中至关重要.
- 在神经功能障碍期间释放的亲炎性介质对神经元的生存有害.
研究的目的:
- 审查和阐明新型药理学药物 (TLR-4/NF-κB抑制剂) 和神经退行症之间的相互作用.
- 探索在NDD中准TLR-4信号的治疗潜力.
- 为开发针对神经退行症的增强治疗策略提供基础.
主要方法:
- 对当前的研究和实验数据进行全面的审查.
- 分析TLR-4/NF-κB信号在神经退行性疾病中的作用.
- 研究针对TLR-4和NF-κB通路的新型药理学药剂.
主要成果:
- 确立了NF-κB激活在中枢神经系统中通过TLR信号传递的关键作用.
- 在阿尔茨海默病,帕金森病,亨廷顿病,ALS和中风中发现了TLR-4/NF-κB抑制剂和神经退行症之间的相互作用.
- 强调了针对TLR-4的重大治疗潜力.
结论:
- 对于神经退行性疾病来说,TLR-4是一种有前途的治疗点.
- 新型TLR-4/NF-κB抑制剂为治疗提供了潜在的途径.
- 本次审查作为未来研究通过TLR-4信号调制对抗NDD的路线图.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
T Cell Types and Functions
999
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
999
Inflammation
53.3K
Overview
53.3K


